Combined Use of Immunoreactivities of RIG-I with Efp/TRIM25 for Predicting Prognosis of Patients With Estrogen Receptor-positive Breast Cancer.

Autor: Junichiro Sato, Kotaro Azuma, Keiichi Kinowaki, Kazuhiro Ikeda, Takuya Ogura, Yutaka Takazawa, Hidetaka Kawabata, Masanobu Kitagawa, Satoshi Inoue, Sato, Junichiro, Azuma, Kotaro, Kinowaki, Keiichi, Ikeda, Kazuhiro, Ogura, Takuya, Takazawa, Yutaka, Kawabata, Hidetaka, Kitagawa, Masanobu, Inoue, Satoshi
Zdroj: Clinical Breast Cancer; Oct2021, Vol. 21 Issue 5, p399-407, 9p
Databáze: Complementary Index